Related Experiment Videos
[Treatment of hypercholesterolemia--the other side of the coin]
1Katedry i Kliniki Chorób Wewnetrznych i Diabetologii A.M. w Warszawie.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|September 1, 1996
Insights
The Framingham Study shows that lower serum cholesterol levels are linked to reduced rates of ischemic heart disease. This long-term analysis confirms cholesterol
Area of Science:
- Cardiovascular epidemiology
- Clinical lipidology
Context:
- The Framingham Heart Study has provided decades of data on cardiovascular disease risk factors.
- Serum cholesterol concentration has been a long-standing focus in heart disease research.
Purpose:
- To analyze the long-term association between serum cholesterol and ischemic heart disease.
- To critically evaluate the impact of cholesterol reduction on disease prevalence.
Summary:
- Over 30 years of follow-up data from the Framingham Study confirms a significant association between serum cholesterol concentration and ischemic heart disease.
- A critical evaluation indicates that decreasing serum cholesterol levels leads to a reduction in the prevalence of ischemic heart disease.
Impact:
- Reinforces the importance of managing cholesterol levels for cardiovascular health.
- Provides evidence supporting public health strategies aimed at lowering cholesterol to prevent heart disease.
Abstract:
Over 30 years of follow up from the Framingham Study an association between serum cholesterol concentration and ischemic heart disease is still analyzed. Critical evaluation shows that a decrease of cholesterol concentration cause a decrease of ischemic heart disease prevalence.